Item Type | Name |
Concept
|
Male
|
Academic Article
|
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.
|
Academic Article
|
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
|
Academic Article
|
Reversible anorgasmia with topiramate therapy for headache: a report of 7 patients.
|
Academic Article
|
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
|
Academic Article
|
Medication-Overuse Headache: Protocols and Outcomes in 149 Consecutive Patients in a Tertiary Brazilian Headache Center.
|
Academic Article
|
Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria.
|
Academic Article
|
Chronic daily headache: identification of factors associated with induction and transformation.
|
Academic Article
|
Cluster headache treatment dilemmas: the experts respond.
|
Academic Article
|
A pivotal moment in 50 years of headache history: the first American Migraine Study.
|
Academic Article
|
Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation.
|
Academic Article
|
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
|
Academic Article
|
Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches.
|
Academic Article
|
Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study.
|
Academic Article
|
Vascular safety of erenumab for migraine prevention.
|
Academic Article
|
Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine.
|
Academic Article
|
Long-Term Outcomes and Clinical Characteristics of Hypnic Headache Syndrome: 40 Patients Series From a Tertiary Referral Center.
|
Academic Article
|
The triptan formulations : how to match patients and products.
|
Academic Article
|
Role of greater occipital nerve blocks and trigger point injections for patients with dizziness and headache.
|
Academic Article
|
Retrospective outcome analyses for headaches in a pain rehabilitation interdisciplinary program.
|
Academic Article
|
Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety.
|
Academic Article
|
Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
|
Academic Article
|
Assessment of adverse events associated with triptans--methods of assessment influence the results.
|
Academic Article
|
The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria.
|
Academic Article
|
Iron deposition in pain-regulatory nuclei in episodic migraine and chronic daily headache by MRI.
|
Academic Article
|
Headache following intracranial neuroendovascular procedures.
|
Academic Article
|
Frequency of Migraine Headaches in Patients With Fibromyalgia.
|
Academic Article
|
Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice.
|
Academic Article
|
Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
|
Academic Article
|
Headache and hemodialysis: a prospective study.
|
Academic Article
|
Rejection and acceptance of possible side effects of migraine prophylactic drugs.
|
Academic Article
|
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
|
Academic Article
|
Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
|
Academic Article
|
Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients.
|
Academic Article
|
Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases.
|
Academic Article
|
Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
|
Academic Article
|
Hemicrania continua: a report of ten new cases.
|
Academic Article
|
Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
|
Academic Article
|
Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches.
|
Academic Article
|
Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine.
|
Academic Article
|
Early onset of efficacy with erenumab in patients with episodic and chronic migraine.
|
Academic Article
|
Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study.
|
Academic Article
|
Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study.
|
Academic Article
|
The effect of weather on headache.
|
Academic Article
|
Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
|
Academic Article
|
Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.
|
Academic Article
|
Characterization of Dizziness After Lasmiditan Usage: Findings From the SAMURAI and SPARTAN Acute Migraine Treatment Randomized Trials.
|
Academic Article
|
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points.
|
Academic Article
|
Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study.
|
Academic Article
|
Memantine in the preventive treatment of refractory migraine.
|
Academic Article
|
An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
|
Academic Article
|
Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
|
Academic Article
|
Dihydroergotamine and its use in migraine with posterior fossa symptoms.
|
Academic Article
|
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
|
Academic Article
|
Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults.
|
Academic Article
|
Medication-overuse headache.
|
Academic Article
|
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials.
|
Academic Article
|
Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial.
|